Organon & Co.
Status: Publicly traded
Direct answer
Organon & Co. is publicly traded on NYSE under the ticker OGN.
Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Brenzys, Renflexis,...
Can you invest in Organon & Co.?
Yes. Organon & Co. is publicly traded on NYSE under the ticker OGN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Organon & Co.
Detailed equity research is provided by MarketSnap.